These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21864731)

  • 21. Novel snail1 target proteins in human colon cancer identified by proteomic analysis.
    Larriba MJ; Casado-Vela J; Pendás-Franco N; Peña R; García de Herreros A; Berciano MT; Lafarga M; Casal JI; Muñoz A
    PLoS One; 2010 Apr; 5(4):e10221. PubMed ID: 20421926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
    López-Boado YS; Puente XS; Alvarez S; Tolivia J; Binderup L; López-Otín C
    Cancer Res; 1997 Sep; 57(18):4091-7. PubMed ID: 9307298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
    Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
    Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3).
    Chakrabarty S; Wang H; Canaff L; Hendy GN; Appelman H; Varani J
    Cancer Res; 2005 Jan; 65(2):493-8. PubMed ID: 15695391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
    Lou YR; Murtola T; Tuohimaa P
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):151-7. PubMed ID: 15862960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells.
    Iessi E; Zischler L; Etringer A; Bergeret M; Morlé A; Jacquemin G; Morizot A; Shirley S; Lalaoui N; Elifio-Esposito SL; Fais S; Garrido C; Solary E; Micheau O
    PLoS One; 2015; 10(5):e0126526. PubMed ID: 26010871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2D-DIGE and MALDI TOF/TOF MS analysis reveal that small GTPase signaling pathways may play an important role in cadmium-induced colon cell malignant transformation.
    Lu J; Zhou Z; Zheng J; Zhang Z; Lu R; Liu H; Shi H; Tu Z
    Toxicol Appl Pharmacol; 2015 Oct; 288(1):106-13. PubMed ID: 26220685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor.
    Smirnoff P; Liel Y; Gnainsky J; Shany S; Schwartz B
    Oncol Res; 1999; 11(6):255-64. PubMed ID: 10691027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maslinic acid, a triterpenic anti-tumoural agent, interferes with cytoskeleton protein expression in HT29 human colon-cancer cells.
    Rufino-Palomares EE; Reyes-Zurita FJ; García-Salguero L; Mokhtari K; Medina PP; Lupiáñez JA; Peragón J
    J Proteomics; 2013 May; 83():15-25. PubMed ID: 23499989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS.
    Fillet M; Cren-Olivé C; Renert AF; Piette J; Vandermoere F; Rolando Ch; Merville MP
    J Proteome Res; 2005; 4(3):870-80. PubMed ID: 15952734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental study of HSP27 differential expression in left sided colon cancer and right sided colon cancer.
    Pei H; Huang L; Liu L; Zhu H; Zeng L; Xiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):277-85. PubMed ID: 21566277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VDR primary targets by genome-wide transcriptional profiling.
    Goeman F; De Nicola F; D'Onorio De Meo P; Pallocca M; Elmi B; Castrignanò T; Pesole G; Strano S; Blandino G; Fanciulli M; Muti P
    J Steroid Biochem Mol Biol; 2014 Sep; 143():348-56. PubMed ID: 24726990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1α,25-Dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells.
    Bessler H; Djaldetti M
    Biomed Pharmacother; 2012 Sep; 66(6):428-32. PubMed ID: 22795808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice.
    Chow EC; Durk MR; Maeng HJ; Pang KS
    Biopharm Drug Dispos; 2013 Oct; 34(7):402-16. PubMed ID: 23897575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer.
    Chang JF; Lin ST; Hung E; Lu YL; Soon May EW; Lo YW; Chou HC; Chan HL
    Toxicol Sci; 2014 Jun; 139(2):396-406. PubMed ID: 24675091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
    Brosseau C; Colston K; Dalgleish AG; Galustian C
    Apoptosis; 2012 Feb; 17(2):164-73. PubMed ID: 22109882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Lamin A in cytoskeleton organization in colorectal cancer cells: a proteomic investigation.
    Foster CR; Robson JL; Simon WJ; Twigg J; Cruikshank D; Wilson RG; Hutchison CJ
    Nucleus; 2011; 2(5):434-43. PubMed ID: 21983087
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Larraga J; Alcolea PJ; Alonso AM; Martins LTC; Moreno I; Domínguez M; Larraga V
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.